SCHEMBL6000461

SCHEMBL6000461

CC(C)CN(Cc1ccc(-c2csc(CN(CC(=O)O)C(=O)c3ccccc3)n2)cc1)c1ccc(C(C)(C)C)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GCGR P47871 3/20 0.44
GIPR P48546 3/20 0.44
PTGES O14684 1/20 0.41
ALOX5 P09917 1/20 0.41
NR1H4 Q96RI1 2/20 0.40
BCHE P06276 1/20 0.38
HDAC1 Q13547 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37
PTPN1 P18031 3/20 0.37
PTPN2 P17706 1/20 0.37
ADRB3 P13945 1/20 0.36
TP53 P04637 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000608 0.90 HDAC1 (0.44) GCGRGIPRPTGESALOX5HDAC1
SCHEMBL6000036 0.88 GCGR (0.46) GCGRGIPRPTGESALOX5NR1H4
SCHEMBL5999373 0.84 PTGER2 (0.43) GCGRGIPRPTPN1ADRB3
SCHEMBL6000195 0.84 GCGR (0.42) GCGRGIPRHDAC1HDAC6PTPN1
SCHEMBL6000909 0.81 KMT2A (0.38) GCGRGIPRBCHEHDAC1HDAC6
SCHEMBL6001010 0.77 PTPN2 (0.41) GCGRGIPRPTPN1PTPN2MEN1
SCHEMBL6001106 0.77 PTPN2 (0.46) HDAC1HDAC6PTPN1PTPN2TP53
SCHEMBL5999114 0.76 PTPN2 (0.46) HDAC1HDAC6PTPN1PTPN2ADRB3
SCHEMBL6000914 0.74 MEN1 (0.44) HDAC1HDAC6ADRB3MEN1KMT2A
SCHEMBL6001139 0.71 PTPN2 (0.51) HDAC1HDAC6PTPN1PTPN2ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 GCGR 194/4885GIPR 138/4885PTGES 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.